Human T-lymphotropic virus type-I infection, survival and cancer risk in southwestern Japan: A prospective cohort study

Cancer Causes and Control

Volumn 14, Issue 9, 2003, Pages 889-896

  Arisawa, Kokichi ^a,c,g   Sobue, Tomotaka ^b   Yoshimi, Itsuro ^b   Soda, Midori ^c   Shirahama, Satoshi ^d   Doi, Hiroshi ^e   Katamine, Shigeru ^a   Saito, Hiroshi ^a   Urata, Minoru ^f  

^a NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

^b NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^c RADIATION EFFECTS RESEARCH FOUNDATION   (Japan)

^d Kamigoto Hospital   (Japan)

^e Department of Health and Welfare ^*  (Japan)

^f Nagasaki Prefectural Kamigoto Public Health Center   (Japan)

^g NAGASAKI UNIVERSITY   (Japan)

Author keywords

Cancer; Cohort study; HTLV I; Mortality; Stomach neoplasms

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; COHORT ANALYSIS; COLORECTAL CANCER; COVARIANCE; DISEASE ASSOCIATION; FEMALE; GENDER; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; JAPAN; LIVER CANCER; LUNG CANCER; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PRIORITY JOURNAL; STOMACH CANCER; T CELL LEUKEMIA;

AGED; CAUSE OF DEATH; COHORT STUDIES; FEMALE; FOOD HABITS; HTLV-I INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; INCIDENCE; JAPAN; LEUKEMIA-LYMPHOMA, T-CELL, ACUTE, HTLV-I-ASSOCIATED; MALE; MIDDLE AGED; NEOPLASMS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 0345059243     PISSN: 09575243     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:CACO.0000003853.82298.96     Document Type: Article

References (39)

1. IARC (1996) Human T-cell lymphotropic viruses. In: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Vol. 67. Human Immunodeficiency Viruses and Human T-cell lymphotropic viruses, Lyon: IARC, pp. 261-390.
2. Mueller NE, Blattner WA (1997) Retroviruses-human T-cell lymphotropic virus. In: Evans AS, Kaslow RA, eds. Viral infections of humans. Epidemiology and control, 4 edn. New York and London: Plenum, pp. 785-813.
3. Murphy EL, Glynn SA, Fridey J, et al. (1999) Increased incidence of infectious diseases during prospective follow-up study of human T lymphotropic virus type II-and I-infected blood donors. Arch Intern Med 159: 1485-1491.
4. Manns A, Hisada M, La Grenade L (1999) Human T-lymphotropic virus type I infection. Lancet 353: 1951-1958.
5. Yoshida M (2001) Multiple viral strategies of HTLV-1 for dysregulation of cell growth control. Annu Rev Immunol 19: 475-496.
6. Grossman WJ, Kimata JT, Wong F-H, Zutter M, Ley TJ, Ratner L (1995) Development of leukemia in mice transgenic for the tax gene of human T-cell leukemia virus type I. Proc Natl Acad Sci USA 92: 1057-1061.
7. Nerenberg M, Hinrichs SH, Reynolds RK, Khoury G, Jay G (1987) The tat gene of human T-lymphotropic virus type 1 induces mesechymal tumors in transgenic mice. Science 237: 1324-1329.
8. Yamada S, Ikeda H, Yamazaki H, et al. (1995) Cytokine-producing mammary carcinomas in transgenic rats carrying the pX gene of human T-lymphotropic virus type I. Cancer Res 55: 2524-2527.
9. Asou N, Kumagai T, Uekihara S, et al. (1986) HTLV-I seroprevalence in patients with malignancy. Cancer 58: 903-907.
10. Kozuru M, Uike N, Muta K, Goto T, Suehiro Y, Nagano M (1996) High occurrence of primary malignant neoplasms in patients with adult T-cell leukemia/lymphoma, their siblings, and their mothers. Cancer 78: 1119-1124.
11. Matsuzaki H, Asou N, Kawaguchi Y, et al. (1990) Human T-cell leukemia virus type 1 associated with small cell lung cancer. Cancer 66: 1763-1768.
12. Miyazaki K, Yamaguchi K, Tohya T, Ohba T, Takatsuki K, Okamura H (1991) Human T-cell leukemia virus type I infection as an oncogenic and prognostic risk factor in cervical and vaginal carcinoma. Obstet Gynecol 77: 107-110.
13. Strickler HD, Rattray C, Escoffery C, et al. (1995) Human T-cell lymphotropic virus type I and severe neoplasia of the cervix in Jamaica. Int J Cancer 61: 23-26.
14. Boschi-Pinto C, Stuver S, Okayama A, et al. (2000) A follow-up study of morbidity and mortality associated with hepatitis C virus infection and its interaction with human T lymphotropic virus type I in Miyazaki, Japan. J Infect Dis 181: 35-41.
15. Iwata K, Ito S, Saito H, et al. (1994) Mortality among inhabitants of an HTLV-1 endemic area in Japan. Jpn J Cancer Res 85: 231-237.
16. Arisawa K, Soda M, Akahoshi M, et al. (1998) Human T-lymphotropic virus type-I infection, antibody titers and cause-specific mortality among atomic-bomb survivors. Jpn J Cancer Res 89: 797-805.
17. Fujino R, Kawato K, Ikeda M, Miyakoshi H, Mizukoshi M, Imai J (1991) Improvement of gelatin particle agglutination test for detection of anti-HTLV-I antibody. Jpn J Cancer Res 82: 367-370.
18. Arisawa K, Soda M, Endo S, et al. (2000) Evaluation of adult T-cell leukemia/lymphoma incidence and its impact on non-Hodgkin lymphoma incidence in southwestern Japan. Int J Cancer 85: 319-324.
19. Sobue T, Yamamoto S, Hara M, Sasazuki S, Sasaki S, Tsugane S (2002) Cigarette smoking and subsequent risk of lung cancer by histologic type in middle-aged Japanese men and women: the JPHC Study. Int J Cancer 99: 245-251.
20. Soda M, Ikeda T (1997) Japan, Nagasaki Prefecture. In: Parkin DM, Whelan SL, Ferlay J, Raymond L, Young J, eds. Cancer Incidence in Five Continents, Vol. VII, Lyon: IARC Scientific Publications, pp. 390-393.
21. Levine PH, Cleghorn F, Manns A, et al. (1994) Adult T-cell leukemia/lymphoma: a working point-score classification for epidemiological studies. Int J Cancer 59: 491-493.
22. SAS Institute, Inc. (1997) SAS/STAT software: Changes and Enhancements through Release 6.12, SAS Institute, Inc., Cary, NC.
23. Lechat MF, Shrager DI, Declercq E, Bertrand F, Blattner WA, Blumberg BS (1997) Decreased survival of HTLV-I carriers in leprosy patients from the Democratic Republic of the Congo: A historical prospective study. J AIDS 15: 387-390.
24. Melbye M, Poulsen A-G, Gallo D, et al. (1998) HTLV-1 infection in a population-based cohort of older persons in Guinea-Bissau, west Africa: risk factors and impact on survival. Int J Cancer 76: 293-298.
25. Nomura AMY, Lee J, Stemmermann GN, Nomura RY, Perez-Perez GI, Blaser MJ (2002) Helicobacter pylori CagA seropositivity and gastric carcinoma risk in a Japanese American Population. J Infect Dis 186: 1138-1144.
26. Isomoto H, Mizuta Y, Fukushima K, et al. (1999) Low prevalence of Helicobacter pylori in individuals with HTLV-I infection. Eur J Gastroenterol Hepatol 11: 497-502.
27. Stuver SO, Tachibana N, Okayama A, Mueller NE (1996) Evaluation of morbidity among human T lymphotropic virus type I carriers in Miyazaki, Japan. J Infect Dis 173: 584-591.
28. Marano BJ, Smith F, Bonanno CA (1993) Helicobacter pylori prevalence in acquired immunodeficiency syndrome. Am J Gastroenterol 88: 687-690.
29. Noach LA, Bosma NB, Jansen J, et al. (1994). Mucosal tumor necrosis factor-α, interleukin-1β, and interleukin-8 production in patients with Helicobacter pylori infection. Scand J Gastroenterol 29: 425-429.
30. Rasso D, Scrigner M, Toma A, et al. (1996) Helicobacter pylori infection enhances mucosal interleukin-1β, interleukin-6, and the soluble receptor of interleukin-2. Int J Clin Lab Res 26: 207-210.
31. El-Omar EM, Carrington M, Chow WH, et al. (2000) Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 404: 398-402.
32. Koyanagi Y, Itoyama Y, Nakamura N, et al. (1993) In vivo infection of human T-cell leukemia virus type I in non-T cells. Virology 196: 25-33.
33. Sawada M, Suzumura A, Kondo N, Marunouchi T (1992) Induction of cytokines in glial cells by trans activator of human T-cell lymphotropic virus type I. FEBS Lett 313: 47-50.
34. Yasunaga J, Sakai T, Nosaka K, et al. (2001) Impaired production of naive T lymphocytes in human T-cell leukemia virus type I-infected individuals: its implications in the immunodeficient state. Blood 97: 3177-3183.
35. Katsuki T, Katsuki K, Imai J, Hinuma Y (1987) Immune suppression in healthy carriers of adult T-cell leukemia retrovirus (HTLV-I): impairment of T-cell control of Epstein-Barr virus-infected B-cells. Jpn J Cancer Res 78: 639-642.
36. Kishihara Y, Furusyo N, Kashiwagi K, Mitsutake A, Kashiwagi S, Hayashi J (2001) Human T lymphotropic virus type 1 infection influences hepatitis C virus clearance. J Infect Dis 184: 1114-1119.
37. Welles SL, Tachibana N, Okayama A, et al. (1994) Decreased reactivity to PPD among HTLV-I carriers in relation to virus and hematologic status. Int J Cancer 56: 337-340.
38. Anttila T, Saikku P, Koskela P, et al. (2001) Serotypes of Chlamydia trachomatis and risk for development of cervical squamous cell carcinoma. JAMA 285: 47-51.
39. Frisch M, Biggar RJ, Engels EA, Goedert JJ (2001) Association of cancer with AIDS-related immunosuppression in adults. JAMA 285: 1736-1745.